Gastroenterology
Conference Coverage
World falls short on HBV, HCV elimination targets
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...
News from the FDA/CDC
FDA expands tenofovir alafenamide (Vemlidy) use to adolescents with chronic HBV
The study met its primary endpoint of percentage of patients with HBV DNA levels less than 20 IU/mL at 24 weeks of therapy.
News
‘Unappreciated’ ties between COVID and gut dysbiosis
“Now that we have uncovered the source of this bacterial imbalance, physicians can better identify those coronavirus patients most at risk of a...
News
Oral FMT on par with colonic FMT for recurrent C. difficile
“We present one of the largest cohorts involving people who received capsule FMT.”
Conference Coverage
Dupilumab improves eosinophilic esophagitis up to 24 weeks
The drug received FDA approval for EoE treatment earlier in 2022.
News
Major U.S. GI societies issue strategic plan on environmental sustainability
Individual and group efforts can help mitigate the effects of climate change on digestive health and health care systems.
Conference Coverage
RBX2660 shows promise in breaking the cycle of recurrent C. difficile
“Even when you expand the patient population to make it more generalizable, we’re still seeing both a high cure rate and a high success rate.”
Conference Coverage
Risk factors ID’d for acute pancreatitis from weight-loss drugs
“With obesity being such a global issue, there are many patients on these GLP-1 agonists.”
Conference Coverage
Some young CRC patients are missing out on genetic counseling, testing
Genetic counseling and testing of patients under 50 with CRC have improved over the last decade, but about 20% of patients still don’t get...
News
Time to ditch clarithromycin for H. pylori?
“This study shows that multiple parts of the United States and Europe have high resistance rates.”